Pim-Inhibitors-Modulators-MCE.docx 免費(fèi)下載
版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
1、 HYPERLINK https:/www.MedChemE/Targets/Pim.html PimPim kinasesThe PIM kinase, also known as serine/threonine kinase plays an important role in cancer biology and is found in three differentisoforms namely PIM-1, PIM-2, and PIM-3. Pim kinases are mainly responsible for cell cycle regulation, antiapop
2、totic activity andthe homing and migration of receptor tyrosine kinases mediated via the JAK/STAT pathway.Pim kinases are over-expressed in various types of tumors and regulate the activation of signaling pathways that are important fortumor cell proliferation, survival and expression of drug efflux
3、 proteins. This makes Pim kinases attractive targets for thedevelopment of anti-cancer chemotherapeutic drugs.www.MedChemE 1 HYPERLINK https:/www.MedChemE/Targets/Pim.html Pim HYPERLINK https:/www.MedChemE/Targets/Pim.html HYPERLINK https:/www.MedChemE/Targets/Pim.html Inhibitors HYPERLINK https:/ww
4、w.MedChemE/_1S,3R,5R_-PIM447-dihydrochloride.html (1S,3R,5R)-PIM447 HYPERLINK https:/www.MedChemE/_1S,3R,5R_-PIM447-dihydrochloride.html HYPERLINK https:/www.MedChemE/_1S,3R,5R_-PIM447-dihydrochloride.html dihydrochloride(1S,3R,5R)-LGH447 dihydrochloride) Cat. No.: HY-19322C HYPERLINK https:/www.Med
5、ChemE/_Z_-SMI-4a.html (Z)-SMI-4aCat. No.: HY-16576A(1S,3R,5R)-PIM447 (dihydrochloride) an PIMinhibitor extracted from patent US 20100056576 A1,compound example 72, has IC values of 0.095 M50for Pim1, 0.522 M for Pim2 and 0.369 M for Pim3.(Z)-SMI-4a is a poten, selective, cell-permeableand ATP-compet
6、itive Pim-1 inhibitor with anIC50 of 24 M and a Ki of 0.6 M. (Z)-SMI-4a alsoinhibits Pim-2 (IC of 100 M), and does not50significantly inhibit the other serine/threonine-or tyrosine-kinases.Purity: 98.13%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development Re
7、portedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/AZD1208.html AZD1208 HYPERLINK https:/www.MedChemE/AZD1208.html HYPERLINK https:/www.MedChemE/AZD1208_hydrochloride.html AZD1208 HYPERLINK https:/www.MedChemE/AZD1208_hydrochloride.html HYPERLINK https:/www.MedChemE/AZD1208_hydrochloride.html hydr
8、ochlorideCat. No.: HY-15604 Cat. No.: HY-15604AAZD1208 is an orally bioavailable, highlyselective PIM kinases inhibitor.AZD1208 hydrochloride is an orally bioavailable,highly selective PIM kinases inhibitor.Purity: 99.90%Clinical Data: Phase 1Size: 10 mM 1 mL, 5 mg, 10 mg, 50 mg, 100 mg, 200 mgPurit
9、y: 98%Clinical Data: Phase 1Size: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/cdk6-pim1-in-1.html CDK6/PIM1-IN-1 HYPERLINK https:/www.MedChemE/cdk6-pim1-in-1.html HYPERLINK https:/www.MedChemE/ck2-erk8-in-1.html CK2/ERK8-IN-1Cat. No.: HY-142696 Cat. No.: HY-135906CDK6/PIM1-IN-1 is a potent and balanced
10、 dualCDK6/PIM1 inhibitor with IC values of 3950and 88 nM, respectively. CDK6/PIM1-IN-1inhibits CDK4 (IC =3.6 nM).50CK2/ERK8-IN-1 is a dual casein kinase 2 (CK2) (Kof 0.25 M) and ERK8 (MAPK15, ERK7) inhibitoriwith IC s of 0.50 M. CK2/ERK8-IN-1 also binds to50PIM1, HIPK2 (homeodomain-interacting prote
11、inkinase 2), and DYRK1A with Ks of 8.65 M, 15.25iM, and 11.9 M, respectively.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98.82%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 10 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/ck2-pim1-in-1.html CK2/PIM1-IN-1 HYPE
12、RLINK https:/www.MedChemE/ck2-pim1-in-1.html HYPERLINK https:/www.MedChemE/cx-6258.html CX-6258Cat. No.: HY-135816 Cat. No.: HY-18095CK2/PIM1-IN-1 is an inhibitor of CK2 and PIM1,with IC s of 3.787 M and 4.327 M for CK2 and50PIM1, respectively.CX-6258 is a potent and kinase selectivepan-Pim kinases
13、inhibitor, with IC s of 5 nM,5025 nM and 16 nM for Pim-1, Pim-2 and Pim-3,respectively.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 99.73%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 25 mg, 50 mg HYPERLINK https:/www.MedChemE/cx-6258-hydrochloride.
14、html CX-6258 HYPERLINK https:/www.MedChemE/cx-6258-hydrochloride.html HYPERLINK https:/www.MedChemE/cx-6258-hydrochloride.html hydrochloride HYPERLINK https:/www.MedChemE/cx-6258-hydrochloride.html HYPERLINK https:/www.MedChemE/CX-6258-hydrochloride-hydrate.html CX-6258 HYPERLINK https:/www.MedChemE
15、/CX-6258-hydrochloride-hydrate.html HYPERLINK https:/www.MedChemE/CX-6258-hydrochloride-hydrate.html hydrochloride HYPERLINK https:/www.MedChemE/CX-6258-hydrochloride-hydrate.html HYPERLINK https:/www.MedChemE/CX-6258-hydrochloride-hydrate.html hydrateCat. No.: HY-18095B Cat. No.: HY-18095ACX-6258 h
16、ydrochloride is a potent and kinaseselective pan-Pim kinases inhibitor, with IC s50of 5 nM, 25 nM and 16 nM for Pim-1, Pim-2 andPim-3, respectively.CX-6258 hydrochloride hydrate is a potent andkinase selective pan-Pim kinases inhibitor, withIC s of 5 nM, 25 nM and 16 nM for Pim-1, Pim-250and Pim-3,
17、respectively.Purity: 99.28%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 50 mgPurity: 98.61%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 50 mg2 Tel: 609-228-6898 Fax: 609-228-5909 Email: salesMedChemE HYPERLINK https:/www.MedChemE/GDC-0339.html GDC-0339
18、 HYPERLINK https:/www.MedChemE/GDC-0339.html HYPERLINK https:/www.MedChemE/GNE-955.html GNE-955Cat. No.: HY-16976 Cat. No.: HY-101783GDC-0339 is a potent, orally bioavailable and welltolerated pan-Pim kinase inhibitor, with Ks ofi0.03 nM, 0.1 nM and 0.02 nM for Pim1, Pim2 andPim3, respectively. GDC-
19、0339 is discovered as apotential treatment of multiple myeloma.GNE-955 is a potent and orally active pan Pimkinase inhibitor with Ks of 0.018, 0.11, 0.08 nMifor Pim1, Pim2, Pim3, respectively.Purity: 99.77%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 50 mg, 100 mgPurity: 98%Clinical Data
20、: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/Hispidulin.html Hispidulin(Dinatin) Cat. No.: HY-N1950 HYPERLINK https:/www.MedChemE/M-110.html M-110Cat. No.: HY-12830Hispidulin is a natural flavone with a broadspectrum of biological activities. Hispidulin is aPim-1 inhibitor
21、 with an IC of 2.71 M.50Purity: 99.34%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 25 mgM-110 is a highly selective, ATP-competitiveinhibitor of PIM kinases with a preference forPIM-3 (IC =47 nM). M-110 inhibits PIM-1 and50PIM-2 with similar IC s of 2.5 M. M-110 inhibits50the
22、 proliferation of prostate cancer cell lineswith IC s of 0.6 to 0.9 M.50Purity: 98.78%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg HYPERLINK https:/www.MedChemE/mnk-pim-in-1.html MNK/PIM-IN-1Cat. No.: HY-132867 HYPERLINK https:/www.MedChemE/PIM-447-dihydrochloride.html PIM-447
23、 HYPERLINK https:/www.MedChemE/PIM-447-dihydrochloride.html HYPERLINK https:/www.MedChemE/PIM-447-dihydrochloride.html dihydrochloride(LGH447 dihydrochloride) Cat. No.: HY-19322BMNK/PIM-IN-1 represents an innovative dualMNK/PIM inhibitor with a good pharmacokineticprofile.PIM447 dihydrochloride (LGH
24、447 dihydrochloride) isa potent, orally available, and selectivepan-PIM kinase inhibitor, with K values of 6,i18, and 9 pM for PIM1, PIM2, and PIM3,respectively. PIM447 dihydrochloride displays dualantimyeloma and bone-protective effects.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5
25、 mgPurity: 99.27%Clinical Data: Phase 1Size: 10 mM 1 mL, 1 mg, 5 mg, 10 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/pim-in-1.html PIM-IN-1 HYPERLINK https:/www.MedChemE/pim-in-1.html HYPERLINK https:/www.MedChemE/PIM1-IN-1.html PIM1-IN-1Cat. No.: HY-142656 Cat. No.: HY-111552PIM-IN-1 is a pan-PI
26、M kinase inhibitor (KG-1,EC = 61 nM; pS6, .50 EC50 = 71 nM).PIM1-IN-1 is a potent and highly selectivePIM1/3 inhibitor, with IC s of 7, 5530 and 7050nM for PIM1, PIM2, and PIM3, respectively,inhibits the phosphorylation of BAD, a downstreamtarget of PIM, with an EC of 262 nM.50Purity: 98%Clinical Da
27、ta: No Development ReportedSize: 1 mg, 5 mgPurity: 99.51%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/pim1-in-2.html PIM1-IN-2 HYPERLINK https:/www.MedChemE/pim1-in-2.html HYPERLINK https:/www.MedChemE/Pim1-AKK1-IN-1.html Pim1/AKK1-IN-1C
28、at. No.: HY-108605(LKB1/AAK1 dual inhibitor) Cat. No.: HY-10371PIM1-IN-2 is a potent and ATP competitive Pim-1inhibitor with a K of 91 nM. PIM1-IN-2 targetsithe ATP-binding kinase hinge region not by formingclassical hydrogen bonds.Pim1/AKK1-IN-1 is a potent multi-kinase inhibitorwith K values of 35
29、 nM/53 nM/75 nM/380 nM fordPim1/AKK1/MST2/LKB1 respectively, and alsoinhibits MPSK1 and TNIK.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98.12%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 50 mgwww.MedChemE 3 HYPERLINK https:/www.MedChemE/PIM447.ht
30、ml PIM447(LGH447) Cat. No.: HY-19322 HYPERLINK https:/www.MedChemE/Quercetagetin.html Quercetagetin(6-Hydroxyquercetin) Cat. No.: HY-N4149PIM447 (LGH447) is a potent, orally available, andselective pan-PIM kinase inhibitor, with Kivalues of 6, 18, and 9 pM for PIM1, PIM2, andPIM3, respectively. PIM4
31、47 displays dualantimyeloma and bone-protective effects. PIM447induces apoptosis.Quercetagetin (6-Hydroxyquercetin) is a flavonoid.Quercetagetin is a moderately potent andselective, cell-permeable pim-1 kinaseinhibitor (IC , 0.34 M). Anti-inflammatory and50anticancer properties.Purity: 98%Clinical D
32、ata: Phase 1Size: 1 mg, 5 mgPurity: 99.24%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg HYPERLINK https:/www.MedChemE/r8-t198wt.html R8-T198wt HYPERLINK https:/www.MedChemE/r8-t198wt.html HYPERLINK https:/www.MedChemE/sel24-b489.html SEL24-B489Cat. No.: HY-P1404 Cat. No.: HY-12
33、0758R8-T198wt is a cell-permeable carboxyl-terminalp27Kip1 peptide exhibits anti-tumor activity byinhibiting Pim-1 kinase.SEL24-B489 is a potent, type I, orally active,dual PIM and FLT3-ITD inhibitor, with Kdvalues of 2 nM for PIM1, 2 nM for PIM2 and 3 nMfor PIM3, respectively.Purity: 98%Clinical Da
34、ta: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/SGI-1776.html SGI-1776Cat. No.: HY-13287 HYPERLINK https:/www.MedChemE/SMI-16a.html SMI-16a(PIM1/2 Kinase Inhibitor VI) Cat. No.: HY-101947SGI-1776 is an inhibit
35、or of Pim kinases, withIC s of 7 nM, 363 nM, and 69 nM for Pim-1, -2 and50-3, respectively.SMI-16a is a selective Pim kinase inhibitorwith IC values of 0.15, 0.02 and 48 M for Pim1,50Pim2 and PC3 cells, respectively.Purity: 99.23%Clinical Data: Phase 1Size: 10 mM 1 mL, 5 mg, 10 mg, 50 mgPurity: 99.7
36、0%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/TCS-PIM-1-1.html TCS HYPERLINK https:/www.MedChemE/TCS-PIM-1-1.html HYPERLINK https:/www.MedChemE/TCS-PIM-1-1.html PIM-1 HYPERLINK https:/www.MedChemE/TCS-PIM-1-1.html HYPERLINK
37、https:/www.MedChemE/TCS-PIM-1-1.html 1 HYPERLINK https:/www.MedChemE/TCS-PIM-1-1.html HYPERLINK https:/www.MedChemE/TCS-PIM-1-4a.html TCS-PIM-1-4a(SC 204330) Cat. No.: HY-18086 (SMI-4a) Cat. No.: HY-16576TCS PIM-1 1 (SC 204330) is a potent, selective andATP-competitive Pim-1 kianse inhibitor with an
38、IC of 50 nM, displays good selectivity over50Pim-2 and MEK1/MEK2 (IC s 20000 nM).50TCS-PIM-1-4a (SMI-4a) is a pan-Pim kinasesinhibitor that blocks mTORC1 activity viaactivation of AMPK. TCS-PIM-1-4a kills a widerange of both myeloid and lymphoid cell lines(IC values ranging from 0.8 M to 40 M).50Purity: 98.03%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 10 mg, 50 mgPurity: 99.90%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/TP-3654.html TP-3654 HYPERLINK https:/www.MedChemE/TP-3654.html HYPERLINK
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 船舶強(qiáng)度課程設(shè)計(jì)
- 二零二五年度抗滑樁施工信息化管理系統(tǒng)合同2篇
- 二零二五年度寵物店轉(zhuǎn)讓及租賃合同3篇
- 燃?xì)夤艿姥簿€員管理制度模版(2篇)
- 課程設(shè)計(jì)無線充電電動(dòng)車
- 二零二五年度應(yīng)急物資儲(chǔ)備與責(zé)任落實(shí)合同3篇
- 食品安全宣傳周方案模版(2篇)
- 二零二五年度汽車尾氣排放檢測(cè)與治理委托合同范本3篇
- 二零二五年度個(gè)人股權(quán)轉(zhuǎn)讓與公司合并重組協(xié)議范本3篇
- 二零二五年圖書館室內(nèi)裝飾合同2篇
- 瑤醫(yī)目診圖-望面診病現(xiàn)用圖解-目診
- 2022年四級(jí)反射療法師考試題庫(kù)(含答案)
- 新《安全生產(chǎn)法》培訓(xùn)測(cè)試題
- 政務(wù)禮儀-PPT課件
- 特種涂料類型——耐核輻射涂料的研究
- 化工裝置常用英語詞匯對(duì)照
- 物資采購(gòu)管理流程圖
- 無牙頜解剖標(biāo)志
- 標(biāo)準(zhǔn)《大跨徑混凝土橋梁的試驗(yàn)方法》
- 格拉斯哥昏迷評(píng)分(GCS)--表格-改良自用
- ISO9001記錄保存年限一覽表
評(píng)論
0/150
提交評(píng)論